Shares of LexaGene Holdings Inc. (CVE:LXG – Get Free Report) were down 19.2% during trading on Wednesday . The company traded as low as C$0.10 and last traded at C$0.11. Approximately 2,135,377 shares changed hands during mid-day trading, an increase of 1,156% from the average daily volume of 170,061 shares. The stock had previously closed at C$0.13.
LexaGene Stock Performance
The stock has a 50-day moving average of C$0.11 and a 200 day moving average of C$0.11. The company has a debt-to-equity ratio of 138.01, a current ratio of 1.39 and a quick ratio of 1.13. The stock has a market capitalization of C$14.77 million, a price-to-earnings ratio of -1.31 and a beta of 2.26.
About LexaGene
LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
Read More
- Five stocks we like better than LexaGene
- P/E Ratio Calculation: How to Assess Stocks
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- What Are Growth Stocks and Investing in Them
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.
